Based on the previous information, to the best of our knowledge, no previous studies were conducted to evaluate the possible role of combined administration of PDE5 inhibitor and loop diuretic, particularly in nanoformulations in chronic renal failure induced chemically. This evidence concerns the gene PDE5A and chronic kidney disease.